Oregon Health and Science University
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Oregon Health and Science University sits in the top decile of US sponsors by registered trial count (#67 of 15,742 sponsors by registered trial count).
Oregon Health and Science University: 546 sponsored US clinical trials, 91 recruiting.
Oregon Health and Science University sponsors 546 registered US clinical trials on ClinicalTrials.gov, 91 of them currently recruiting, and 370 completed. 73 of these trials are in Phase 3-4 (later-stage) and 92 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 6 trials.
Top-decile sponsor footprint
Oregon Health and Science University ranks in the top decile of sponsors by registered trial count (#67 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
370 of 420 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
546 total, page 1 of 11
A Phase II Study With Exploratory Outcomes of Fucose Supplementation in GLUT1 Deficiency Syndrome
NCT07432490
Mavacamten to Aficamten Transition in Patients With Obstructive Hypertrophic Cardiomyopathy
NCT07600177
Insights in Endocervical Mucus Secretion
NCT07111247
Light Therapy to Improve Sleep in TBI: Sleep-active Biomarkers and Glymphatic Function
NCT07601841
At-Home Transcutaneous Tibial Nerve Stimulation for Overactive Bladder in Rural Women
NCT07178314
Implementing Powered Mobility in Early Childhood Settings for Children With Cerebral Palsy
NCT07220590
Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study
NCT05916469
Placental Risk Assessment to CusTomize Individualized Pregnancy Care and Evaluation
NCT07144839
Physical Therapy After Endometriosis Excision
NCT07127783
Use of Cervical Cap and Menstrual Disc for Application of Topical Anesthetic Prior to IUD Insertion
NCT06891794
STELLA-FTD: Examination of a Behavior Change Intervention for FTD Family Care Partners
NCT06613204
TURN-IT FOG: Improving Turning and Freezing of Gait in People With PD
NCT06815302
Brief Sleep Intervention for Bedtime Resistance
NCT06970392
Patient Empowerment and Agency Through Intrapartum Counseling and Education
NCT06787521
The MOUD Plus Pilot: Counseling and Peer Support to Support Retention for Medically Complex Patients With Opioid Use Disorder Seen In Primary Care
NCT06837662
OTAGO Exercise Program and Motivational Interviewing
NCT06931067
Guselkumab in the Treatment of Adults With Pyoderma Gangrenosum (PG)
NCT06563323
eDoula Feasibility and Acceptability
NCT06785467
DBS TaT in Peer-assisted Telemedicine for Hepatitis C
NCT06409169
Cortical Correlates of Gait in Parkinson's Disease: Impact of Medication and Cueing
NCT05818189
Early Amiodarone in Shockable Cardiac Arrest
NCT06680869
Exhaled Breath: A Novel Technique for Rapid Diagnosis of Respiratory Diseases and Infections
NCT06775106
Closed Loop Context Aware AID
NCT06676657
Diet and Active Lifestyle - Yuuyaraq (The Yup'ik Way of Life)
NCT06629610
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Small Tonsils
NCT06258837
Quantification & Classification of Inflammatory Cells in Uveitis Using OCT
NCT07065747
Rural Community Peer Partnerships for Improving Methamphetamine-Associated Heart Failure Screening and Engagement
NCT06461962
Tele-Collaborative Outreach to Rural Patients With Chronic Pain
NCT06091202
Support Via Technology: Living and Learning With Advancing Dementia-REVISED
NCT06460012
The Influence of Sleep on Cardiovascular Outcomes
NCT06535178
Wearable Technology to Characterize and Treat mTBI Subtypes: Biofeedback-Based Precision Rehabilitation
NCT06381674
Pilot Study of Open Label Homocysteine Management Therapy in Levodopa-treated Parkinson's Disease
NCT06772220
Bilateral Infant Stimulation Study
NCT06353243
Monoferric for Prenatal Iron Deficiency
NCT05763043
Collaboration Oriented Approach to Controlling High Blood Pressure
NCT06124716
Optimizing Research With Diverse Families - Feasibility and Acceptability Study (FAST)
NCT06133231
The Z Stitch Early Bed Rest Assessment Study
NCT06087497
Sleep and Metabolism
NCT05775627
Impact of Two Dietary Interventions on Simple Carbohydrate Intolerance
NCT06057376
Vitamin C to Decrease Effects of Smoking in Pregnancy on Infant Lung Function (VCSIP) Longer Term Follow Up
NCT06106646
Total Intravenous Versus Inhalational Anesthesia- A Geriatric Anesthesia Study
NCT06036095
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
NCT05508971
Immunogenicity of Yellow Fever Vaccine 17D in Adults With Prior 17D Vaccination
NCT05859490
PAI-1, tPA, TFPI and HEECs in Uterine Hemostasis
NCT05862805
Endometrial Biopsy in Progestin Contraceptive Users
NCT05760144
Proximal Risk for Suicide in Adolescents
NCT06400810
Clinic-Based School Readiness Coaching
NCT06390215
Focus Groups in Ethnically and Racially Diverse Families
NCT05930886
Fetoscopic Neural Tube Defect Repair
NCT06946563
Circadian Time Restricted Eating
NCT05628012
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 52 |
| Phase 2 | 40 |
| Phase 3 | 6 |
| Phase 4 | 67 |
Therapeutic Areas
What is open in the Oregon Health and Science University pipeline
91 recruiting of 546 indexed (17% open); 370 completed (68%).
Phase mix: 73 late (III/IV) vs 92 early (I/II) (balanced across stages).
Top condition: Obesity (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Oregon Health and Science University: open-pipeline peers nationwide
Peers matched on 546 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
Oregon Health and Science University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 546 trials (± recruiting share)
- Ohio State University · 552 trials · 21% recruiting
- Amgen · 558 trials · 10% recruiting
- Merck Sharp & Dohme · 558 trials · 22% recruiting
- Virginia Commonwealth University · 558 trials · 14% recruiting
Sponsors near 17% open enrollment (± trial volume)
- Adagene · 17% recruiting · 6 trials
- Agendia · 17% recruiting · 6 trials
- Akamis Bio · 17% recruiting · 6 trials
- Angiodynamics · 17% recruiting · 12 trials
Related
What to do with this Oregon Health and Science University page
546 registered trials is a research-attention snapshot, not an endorsement of Oregon Health and Science University or any single study.
- 91 of Oregon Health and Science University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Oregon Health and Science University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Oregon Health and Science University pipeline card: 546 registered trials from official public datasets.Report a data error.